SKIN PE Ratio & Valuation,Is SKIN Overvalued

SKIN Relative Valuation

SKIN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SKIN is overvalued; if below, it's undervalued.

Historical Valuation

Beauty Health Co (SKIN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 48.27. The fair price of Beauty Health Co (SKIN) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 1.41 USD , Beauty Health Co is Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：1.41

Fair

Undervalued

9.25

9.53

EV/EBITDA

Beauty Health Co. (SKIN) has a current EV/EBITDA of 9.53. The 5-year average EV/EBITDA is 36.73. The thresholds are as follows: Strongly Undervalued below -52.75, Undervalued between -52.75 and -8.01, Fairly Valued between 81.48 and -8.01, Overvalued between 81.48 and 126.22, and Strongly Overvalued above 126.22. The current Forward EV/EBITDA of 9.53 falls within the Historic Trend Line -Fairly Valued range.

-40.57

EV/EBIT

Beauty Health Co. (SKIN) has a current EV/EBIT of -40.57. The 5-year average EV/EBIT is 83.70. The thresholds are as follows: Strongly Undervalued below -530.30, Undervalued between -530.30 and -223.30, Fairly Valued between 390.69 and -223.30, Overvalued between 390.69 and 697.69, and Strongly Overvalued above 697.69. The current Forward EV/EBIT of -40.57 falls within the Historic Trend Line -Fairly Valued range.

0.59

Beauty Health Co. (SKIN) has a current PS of 0.59. The 5-year average PS is 3.53. The thresholds are as follows: Strongly Undervalued below -3.70, Undervalued between -3.70 and -0.09, Fairly Valued between 7.15 and -0.09, Overvalued between 7.15 and 10.77, and Strongly Overvalued above 10.77. The current Forward PS of 0.59 falls within the Historic Trend Line -Fairly Valued range.

6.45

P/OCF

Beauty Health Co. (SKIN) has a current P/OCF of 6.45. The 5-year average P/OCF is 27.82. The thresholds are as follows: Strongly Undervalued below -103.28, Undervalued between -103.28 and -37.73, Fairly Valued between 93.37 and -37.73, Overvalued between 93.37 and 158.92, and Strongly Overvalued above 158.92. The current Forward P/OCF of 6.45 falls within the Historic Trend Line -Fairly Valued range.

21.86

P/FCF

Beauty Health Co. (SKIN) has a current P/FCF of 21.86. The 5-year average P/FCF is -259.46. The thresholds are as follows: Strongly Undervalued below -2513.64, Undervalued between -2513.64 and -1386.55, Fairly Valued between 867.63 and -1386.55, Overvalued between 867.63 and 1994.72, and Strongly Overvalued above 1994.72. The current Forward P/FCF of 21.86 falls within the Historic Trend Line -Fairly Valued range.

Beauty Health Co (SKIN) has a current Price-to-Book (P/B) ratio of 2.73. Compared to its 3-year average P/B ratio of 5.15 , the current P/B ratio is approximately -46.94% higher. Relative to its 5-year average P/B ratio of 11.82, the current P/B ratio is about -76.88% higher. Beauty Health Co (SKIN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.39%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.51% , the current FCF yield is about -100.00% lower.

2.73

P/B

Median3y

5.15

Median5y

11.82

21.89

FCF Yield

Median3y

2.39

Median5y

0.51

Competitors Valuation Multiple

The average P/S ratio for SKIN's competitors is 2.08, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN) exhibits a P/S ratio of , which is -100% above the industry average. Given its robust revenue growth of -10.34%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of SKIN decreased by 11.32% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -6.02 to -7.93.

The secondary factor is the Revenue Growth, contributed -10.34%to the performance.

Overall, the performance of SKIN in the past 1 year is driven by P/E Change. Which is more unsustainable.

-10.34%

78.80M → 70.66M

Revenue Growth

-32.74%

-23.21 → -15.61

Margin Expansion

31.76%

-6.02 → -7.93

P/E Change

-11.32%

1.59 → 1.41

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Beauty Health Co (SKIN) currently overvalued or undervalued?

What is Beauty Health Co (SKIN) fair value?

SKIN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Beauty Health Co (SKIN) is between +Inf to +Inf according to relative valuation methord.

How does SKIN's valuation metrics compare to the industry average?

The average P/S ratio for SKIN's competitors is 2.08, providing a benchmark for relative valuation. Beauty Health Co Corp (SKIN) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -10.34%, this premium appears unsustainable.

What is the current P/B ratio for Beauty Health Co (SKIN) as of Dec 17 2025?

As of Dec 17 2025, Beauty Health Co (SKIN) has a P/B ratio of 2.73. This indicates that the market values SKIN at 2.73 times its book value.

What is the current FCF Yield for Beauty Health Co (SKIN) as of Dec 17 2025?

As of Dec 17 2025, Beauty Health Co (SKIN) has a FCF Yield of 0.00%. This means that for every dollar of Beauty Health Co’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Beauty Health Co (SKIN) as of Dec 17 2025?

As of Dec 17 2025, Beauty Health Co (SKIN) has a Forward P/E ratio of 9.25. This means the market is willing to pay $9.25 for every dollar of Beauty Health Co’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Beauty Health Co (SKIN) as of Dec 17 2025?

As of Dec 17 2025, Beauty Health Co (SKIN) has a Forward P/S ratio of 0.00. This means the market is valuing SKIN at $0.00 for every dollar of expected revenue over the next 12 months.

SKIN Valuation